Target intelligence / Profile preview

Neuroblastoma RAS viral oncogene homolog mRNA G-quadruplex (NRAS mRNA G4)

Target
NRAS mRNA G4
Molecular classification
RNA G-quadruplex, Non-canonical nucleic acid structure, Cis-regulatory element, Other
01

Overview

The NRAS mRNA G-quadruplex is a non-canonical, four-stranded secondary structure located within the 5' untranslated region (UTR) of the NRAS (Neuroblastoma RAS viral oncogene homolog) transcript. This structure is formed by guanine-rich sequences that fold into a stable arrangement through Hoogsteen hydrogen bonding, serving as a natural cis-regulatory element that modulates NRAS protein synthesis. Biologically, the G-quadruplex acts as a translational repressor by obstructing the scanning of the 43S ribosomal pre-initiation complex along the mRNA leader sequence. In many human cancers, such as melanoma and various leukemias, NRAS is constitutively activated or overexpressed, making it a primary driver of uncontrolled cell proliferation and survival. Because the NRAS protein has historically been difficult to target directly with small molecules, the NRAS mRNA G-quadruplex has emerged as a promising alternative therapeutic target. Small-molecule ligands designed to stabilize this structure can effectively downregulate NRAS expression at the translational level, leading to reduced oncogenic signaling and the induction of apoptosis in cancer cells.

Other names
NRAS 5'-UTR G-quadruplexNRAS rG4NRAS mRNA G-quadruplex structureNRAS G-quadruplex
02

Mechanism of action

Small-molecule ligands bind to and stabilize the G-quadruplex structure within the 5' untranslated region (UTR) of the NRAS mRNA, creating a physical barrier that impedes ribosomal scanning and inhibits translation initiation, or alternatively, induces targeted mRNA degradation through reactive oxygen species (ROS) generation in photodynamic therapy.

03

Biological functions

Translation regulationInhibition of translation initiationPost-transcriptional regulationmRNA stability modulation
04

Disease associations

CancerMelanomaNeuroblastomaColorectal cancerAcute myeloid leukemiaRAS-driven malignancy
05

Safety considerations

Off-target binding to other genomic or transcriptomic G-quadruplexesPotential systemic toxicity due to lack of ligand selectivityChallenges in targeted delivery to tumor tissuesPotential for unintended effects on global translation
06

Interacting drugs

B3C

8 more in the full profile.

07

Biomarkers

NRAS mutation status (e.g., Q61, G12, G13)NRAS protein expression levelsNRAS mRNA levels

Beyond the preview

Go deeper on Neuroblastoma RAS viral oncogene homolog mRNA G-quadruplex (NRAS mRNA G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma RAS viral oncogene homolog mRNA G-quadruplex (NRAS mRNA G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call